Salvatore Piscuoglio
Salvatore Piscuoglio
Verified email at
Cited by
Cited by
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ...
Nature communications 6 (1), 8839, 2015
Genomic characterization of metastatic breast cancers
F Bertucci, CKY Ng, A Patsouris, N Droin, S Piscuoglio, N Carbuccia, ...
Nature 569 (7757), 560-564, 2019
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ...
Hepatology 59 (3), 911-923, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, HH Won, CKY Ng, P Nuciforo, ...
Annals of oncology 25 (9), 1729-1735, 2014
Breast cancer intra-tumor heterogeneity
LG Martelotto, CKY Ng, S Piscuoglio, B Weigelt, JS Reis-Filho
Breast Cancer Research 16, 1-11, 2014
Organoid models of human liver cancers derived from tumor needle biopsies
S Nuciforo, I Fofana, MS Matter, T Blumer, D Calabrese, T Boldanova, ...
Cell reports 24 (5), 1363-1376, 2018
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer
E Donnarumma, D Fiore, M Nappa, G Roscigno, A Adamo, M Iaboni, ...
Oncotarget 8 (12), 19592-19608, 2017
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian CancercfDNA Detection of BRCA1 and BRCA2 Reversion Mutations
B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, ...
Clinical Cancer Research 23 (21), 6708-6720, 2017
The protein histidine phosphatase LHPP is a tumour suppressor
SK Hindupur, M Colombi, SR Fuhs, MS Matter, Y Guri, K Adam, M Cornu, ...
Nature 555 (7698), 678-682, 2018
Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas
AM Schultheis, CKY Ng, MR De Filippo, S Piscuoglio, GS Macedo, ...
Journal of the National Cancer Institute 108 (6), djv427, 2016
The genomic landscape of male breast cancers
S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ...
Clinical Cancer Research 22 (16), 4045-4056, 2016
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
CKY Ng, LG Martelotto, A Gauthier, HC Wen, S Piscuoglio, RS Lim, ...
Genome biology 16, 1-21, 2015
Genomic landscape of adenoid cystic carcinoma of the breast
LG Martelotto, MR De Filippo, CKY Ng, R Natrajan, L Fuhrmann, J Cyrta, ...
The Journal of pathology 237 (2), 179-189, 2015
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations
LG Martelotto, CKY Ng, MR De Filippo, Y Zhang, S Piscuoglio, RS Lim, ...
Genome biology 15 (10), 1-20, 2014
The Landscape of Somatic Genetic Alterations in Metaplastic Breast CarcinomasGenetics of Metaplastic Breast Carcinomas
CKY Ng, S Piscuoglio, FC Geyer, KA Burke, F Pareja, CA Eberle, RS Lim, ...
Clinical cancer research 23 (14), 3859-3870, 2017
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
LG Martelotto, T Baslan, J Kendall, FC Geyer, KA Burke, L Spraggon, ...
Nature medicine 23 (3), 376-385, 2017
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ...
Nature communications 9 (1), 1816, 2018
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene …
S Piscuoglio, CKY Ng, M Murray, KA Burke, M Edelweiss, FC Geyer, ...
The Journal of pathology 238 (4), 508-518, 2016
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
R Gao, RKR Kalathur, M Coto‐Llerena, C Ercan, D Buechel, S Shuang, ...
EMBO Molecular Medicine 13 (12), e14351, 2021
The system can't perform the operation now. Try again later.
Articles 1–20